
NetTargets revolutionizes drug discovery and development by leveraging AI-enhanced systems biology, built upon over 20 years of research. Their approach integrates biological experimentation, mathematical modeling, and computer simulation to uncover hidden biological mechanisms and predict drug efficacy, thereby reducing the risks associated with clinical trials. By providing interpretable predictions, NetTargets empowers better decision-making in drug development, aiming for successful drug discovery with a focus on mechanism-based treatment strategy analysis. The company collaborates with global biopharmaceutical companies and is seeking talent with expertise in chemistry, biology, and computing.

NetTargets revolutionizes drug discovery and development by leveraging AI-enhanced systems biology, built upon over 20 years of research. Their approach integrates biological experimentation, mathematical modeling, and computer simulation to uncover hidden biological mechanisms and predict drug efficacy, thereby reducing the risks associated with clinical trials. By providing interpretable predictions, NetTargets empowers better decision-making in drug development, aiming for successful drug discovery with a focus on mechanism-based treatment strategy analysis. The company collaborates with global biopharmaceutical companies and is seeking talent with expertise in chemistry, biology, and computing.